Jim Cramer said Tuesday that Pfizer is setting itself up to split with the creation of its Pfizer Innovative Health and Pfizer Essential Health.
The biopharmaceuticals company released its second-quarter earnings Tuesday at 64 cents per share, beating analysts estimates of 62 cents per share. Its revenue came in at $13.1 billion, edging past expectations for $13 billion.
"I think this is a nice prep," he said.
The drugmaker did not offer hints on whether it will split in its earnings report, but after Pfizer ended its acquisition of Botox-maker Allergan in April, the company put the idea back on the table.
CEO Ian Read said in April he would reach a decision by the end of 2016 on whether to break up the company.